0001209191-22-013770.txt : 20220228 0001209191-22-013770.hdr.sgml : 20220228 20220228185033 ACCESSION NUMBER: 0001209191-22-013770 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220225 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERRY GREGORY D CENTRAL INDEX KEY: 0001236371 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40227 FILM NUMBER: 22692711 MAIL ADDRESS: STREET 1: C/O IMMUNOGEN, INC. STREET 2: 830 WINTER ST. CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Finch Therapeutics Group, Inc. CENTRAL INDEX KEY: 0001733257 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823433558 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 INNER BELT ROAD CITY: SOMERVILLE STATE: MA ZIP: 02143 BUSINESS PHONE: 617-229-6499 MAIL ADDRESS: STREET 1: 200 INNER BELT ROAD CITY: SOMERVILLE STATE: MA ZIP: 02143 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-25 0 0001733257 Finch Therapeutics Group, Inc. FNCH 0001236371 PERRY GREGORY D C/O FINCH THERAPEUTICS GROUP, INC. 200 INNER BELT ROAD, SUITE 400 SOMERVILLE MA 02143 0 1 0 0 Chief Financial Officer Employee Stock Option (right to buy) 8.61 2022-02-25 4 A 0 80000 0.00 A 2032-02-24 Common Stock 80000 80000 D This option vests in equal monthly installments over a four-year period commencing on February 1, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date. /s/ Trey Reilly, Attorney-in-Fact 2022-02-28